Reducing dyspeptic symptoms in children: proton pump inhibitor vs. H2 receptor antagonist

Background Dyspepsia is known as a leading cause of upper gastrointestinal tract morbidity. If left untreated, dyspepsia may become chronic. Dyspeptic symptoms manifest as epigastric pain, heartburn, nausea, hematemesis, or melena. Experimental studies have shown that omeprazole is more effective at...

Full description

Bibliographic Details
Main Authors: Tien Budi Febriani, Titis Widowati, Mohammad Juffrie
Format: Article
Language:English
Published: Indonesian Pediatric Society Publishing House 2014-08-01
Series:Paediatrica Indonesiana
Subjects:
Online Access:https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/638
id doaj-02e70043c8bf464c9b5a060c4507cd3d
record_format Article
spelling doaj-02e70043c8bf464c9b5a060c4507cd3d2020-11-25T00:10:08ZengIndonesian Pediatric Society Publishing HousePaediatrica Indonesiana0030-93112338-476X2014-08-0154419820110.14238/pi54.4.2014.198-201506Reducing dyspeptic symptoms in children: proton pump inhibitor vs. H2 receptor antagonistTien Budi Febriani0Titis Widowati1Mohammad Juffrie2Department of Child Health, Gadjah Mada University Medical School/Sardjito General HospitalDepartment of Child Health, Gadjah Mada University Medical School/Sardjito General HospitalDepartment of Child Health, Gadjah Mada University Medical School/Sardjito General HospitalBackground Dyspepsia is known as a leading cause of upper gastrointestinal tract morbidity. If left untreated, dyspepsia may become chronic. Dyspeptic symptoms manifest as epigastric pain, heartburn, nausea, hematemesis, or melena. Experimental studies have shown that omeprazole is more effective at reducing heartburn than ranitidine in adults. However, there have been few studies comparing the effects of proton pump inhibitors to Hz receptor antagonists for reducing dyspeptic symptoms in children. Objective To compare the effect of omeprazole with ranitidine for reducing dyspeptic symptoms . Methods We performed a double-blind randomized controlled trial (RCT) at Sardjito Hospital and three community h ealth centers in the Sleman District from June to November 2012. We recruited children aged 3-18 years with dyspepsia. Subjects were allocated into two groups using block randomization: the proton pump inhibitor (omeprazole) and the Hz receptor antagonist (ranitidine) groups. According to the groups, either omeprazole (0.4-0 .8 mg/kg/dose) or ranitidine (2-4 mg/kg/dose) , respectively, were taken twice daily for 5 days. Dyspepsia was clinically diagnosed using the new Rome III criteria. Both groups were monitored for 5 days to assess for a reduction of dyspeptic symptoms. Results Significantly more subjects in the omeprazole group recovered from dyspeptic symptoms than in the ranitidine group (RR= 4.87; 95%CI 1.5 to 15.3; P=0.005). Conclusion Omeprazole was 4.87 (95% CI 1.5 to 15.3) times better than ranitidine in reducing dyspeptic symptoms on children aged 3-18 years with dyspepsia.https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/638dyspepsia, omeprazole, ranitidine
collection DOAJ
language English
format Article
sources DOAJ
author Tien Budi Febriani
Titis Widowati
Mohammad Juffrie
spellingShingle Tien Budi Febriani
Titis Widowati
Mohammad Juffrie
Reducing dyspeptic symptoms in children: proton pump inhibitor vs. H2 receptor antagonist
Paediatrica Indonesiana
dyspepsia, omeprazole, ranitidine
author_facet Tien Budi Febriani
Titis Widowati
Mohammad Juffrie
author_sort Tien Budi Febriani
title Reducing dyspeptic symptoms in children: proton pump inhibitor vs. H2 receptor antagonist
title_short Reducing dyspeptic symptoms in children: proton pump inhibitor vs. H2 receptor antagonist
title_full Reducing dyspeptic symptoms in children: proton pump inhibitor vs. H2 receptor antagonist
title_fullStr Reducing dyspeptic symptoms in children: proton pump inhibitor vs. H2 receptor antagonist
title_full_unstemmed Reducing dyspeptic symptoms in children: proton pump inhibitor vs. H2 receptor antagonist
title_sort reducing dyspeptic symptoms in children: proton pump inhibitor vs. h2 receptor antagonist
publisher Indonesian Pediatric Society Publishing House
series Paediatrica Indonesiana
issn 0030-9311
2338-476X
publishDate 2014-08-01
description Background Dyspepsia is known as a leading cause of upper gastrointestinal tract morbidity. If left untreated, dyspepsia may become chronic. Dyspeptic symptoms manifest as epigastric pain, heartburn, nausea, hematemesis, or melena. Experimental studies have shown that omeprazole is more effective at reducing heartburn than ranitidine in adults. However, there have been few studies comparing the effects of proton pump inhibitors to Hz receptor antagonists for reducing dyspeptic symptoms in children. Objective To compare the effect of omeprazole with ranitidine for reducing dyspeptic symptoms . Methods We performed a double-blind randomized controlled trial (RCT) at Sardjito Hospital and three community h ealth centers in the Sleman District from June to November 2012. We recruited children aged 3-18 years with dyspepsia. Subjects were allocated into two groups using block randomization: the proton pump inhibitor (omeprazole) and the Hz receptor antagonist (ranitidine) groups. According to the groups, either omeprazole (0.4-0 .8 mg/kg/dose) or ranitidine (2-4 mg/kg/dose) , respectively, were taken twice daily for 5 days. Dyspepsia was clinically diagnosed using the new Rome III criteria. Both groups were monitored for 5 days to assess for a reduction of dyspeptic symptoms. Results Significantly more subjects in the omeprazole group recovered from dyspeptic symptoms than in the ranitidine group (RR= 4.87; 95%CI 1.5 to 15.3; P=0.005). Conclusion Omeprazole was 4.87 (95% CI 1.5 to 15.3) times better than ranitidine in reducing dyspeptic symptoms on children aged 3-18 years with dyspepsia.
topic dyspepsia, omeprazole, ranitidine
url https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/638
work_keys_str_mv AT tienbudifebriani reducingdyspepticsymptomsinchildrenprotonpumpinhibitorvsh2receptorantagonist
AT titiswidowati reducingdyspepticsymptomsinchildrenprotonpumpinhibitorvsh2receptorantagonist
AT mohammadjuffrie reducingdyspepticsymptomsinchildrenprotonpumpinhibitorvsh2receptorantagonist
_version_ 1725409137114742784